Modulation of α(1B)-adrenoceptor expression by agonist and protein kinase inhibitors

European Journal of Pharmacology

Volumn 340, Issue 2-3, 1997, Pages 267-275

  Bird, Kristin S ^a   Anderson, Jodi L ^a   Toews, Myron L ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

(1B) Adrenoceptor; Genistein; Protein kinase; Receptor down regulation; Receptor up regulation; Staurosporine

Indexed keywords

2 [1 (3 DIMETHYLAMINOPROPYL) 3 INDOLYL] 3 (3 INDOLYL)MALEIMIDE; ADRENALIN; ALPHA 1B ADRENERGIC RECEPTOR; CYCLOHEXIMIDE; DAIDZEIN; GENISTEIN; PHORBOL 12 ACETATE 13 MYRISTATE; PROTEIN KINASE C INHIBITOR; PROTEIN KINASE INHIBITOR; STAUROSPORINE; ALPHA 1 ADRENERGIC RECEPTOR; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; ENZYME INHIBITOR; PROTEIN KINASE C; PROTEIN SYNTHESIS INHIBITOR;

ANIMAL CELL; ARTICLE; CHO CELL; CONTROLLED STUDY; GENETIC REGULATION; MODULATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR DOWN REGULATION; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION; ANIMAL; BIOSYNTHESIS; CELL ADHESION; CELL LINE; DRUG ANTAGONISM; DRUG EFFECT; HAMSTER; UPREGULATION;

ADRENERGIC ALPHA-AGONISTS; ANIMALS; CELL ADHESION; CELL LINE; CHO CELLS; CRICETINAE; ENZYME INHIBITORS; EPINEPHRINE; GENISTEIN; PROTEIN KINASE C; PROTEIN KINASE INHIBITORS; PROTEIN SYNTHESIS INHIBITORS; RECEPTORS, ADRENERGIC, ALPHA-1; SIGNAL TRANSDUCTION; STAUROSPORINE; UP-REGULATION;

EID: 0031565075     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(97)01418-0     Document Type: Article

References (27)

1. Akiyama T., Ishida J., Nakagawa S., Ogawara H., Watanabe S., Itoh N., Shibuya M., Fukami Y. Genistein, a specific inhibitor of tyrosine-specific protein kinases. J. Biol. Chem. 262:1987;5592-5595.
2. 2 receptor stimulation. Mol. Pharmacol. 43:1993;349-355.
3. Bertrand R., Solary E., O'Connor P., Kohn K.W., Pommier Y. Induction of a common pathway of apoptosis by staurosporine. Exptl. Cell Res. 211:1994;314-321.
4. 1-adrenergic receptor. Proc. Natl. Acad. Sci. USA. 85:1988;7159-7163.
5. Fallon R.J. Staurosporine inhibits a tyrosine protein kinase in human hepatoma cell membranes. Biochem. Biophys. Res. Commun. 170:1990;1191-1196.
6. Filtz T.M., Artymyshyn R.P., Guan W., Molinoff P.B. Paradoxical regulation of dopamine receptors in transfected 293 cells. Mol. Pharmacol. 44:1993;371-379.
7. 1-Adrenergic receptor subtypes: molecular structure, function, and signaling. Circ. Res. 78:1996;737-749.
8. Hadcock J.R., Malbon C.C. Agonist regulation of gene expression of adrenergic receptors and G proteins. J. Neurochem. 60:1993;1-9.
9. S in the transfected Chinese hamster ovary cells. Mol. Pharmacol. 48:1995;392-400.
10. Ivins K.J., Luedtke R.R., Artymyshyn R.P., Molinoff P.B. Regulation of dopamine D2 receptors in a novel cell line (SUP1). Mol. Pharmacol. 39:1991;531-539.
11. Lohse M.J. Molecular mechanisms of membrane receptor desensitization. Biochim. Biophys. Acta. 1179:1993;171-188.
12. Kobilka B. Adrenergic receptors as models for G protein-coupled receptors. Ann. Rev. Neurosci. 15:1992;87-114.
13. 1-adrenergic receptor mRNA levels. J. Biol. Chem. 266:1991;2233-2238.
14. Post G.R., Brown J.H. G protein-coupled receptors and signaling pathways regulating growth responses. FASEB J. 10:1991;741-749.
15. Ramamoorthy J.D., Ramamoorthy S., Papapetropoulos A., Catravas J.D., Leibach F.H., Ganapathy V. Cyclic AMP-independent up-regulation of the human serotonin transporter by staurosporine in choriocarcinoma cells. J. Biol. Chem. 270:1995;17189-17195.
16. Rasouly D., Rahamim E., Lester D., Matsuda Y., Lazarovici P. Staurosporine-induced neurite outgrowth in PC12 cells is independent of protein kinase C inhibition. Mol. Pharmacol. 42:1992;35-43.
17. Rosenthal H.E. Graphic method for the determination and presentation of binding parameters in a complex system. Anal. Biochem. 20:1967;525-532.
18. 1-MF2 smooth muscle cells. J. Pharmacol. Exptl. Ther. 272:1995;215-223.
19. Sowa G., Przewlocki R. Enhancing effect of staurosporine on NO production in rat peritoneal macrophages via a protein kinase C-independent mechanism. Br. J. Pharmacol. 116:1995;1711-1712.
20. Starr S., Kozell L.B., Neve K.A. Drug-induced up-regulation of dopamine D2 receptors on cultured cells. J. Neurochem. 65:1995;569-577.
21. 2+ dependent protein kinase. Biochem. Biophys. Res. Commun. 135:1986;397-402.
22. 3-adrenergic receptor expression via multiple cAMP response elements. Proc. Natl. Acad. Sci. USA. 89:1992;4490-4494.
23. Toews, M.L., Shreve, P.E., Bylund, D.B., 1991. Regulation of adrenergic receptors. In: Martinez, J.R. et al. (Eds.), Signaling Mechanisms in Secretory and Immune Cells. San Francisco Press, San Francisco, CA, pp. 1-17.
24. Toullec D., Pianetti P., Coste H., Bellevergue P., Grand-Perret T., Ajakane M., Baudet V., Boissin P., Boursier E., Loriolle F., Duhamel L., Charon D., Kirilovsky J. The bisindolylmaleimide GF 109203X is a potent and selective inhibitor of protein kinase C. J. Biol. Chem. 266:1991;15771-15781.
25. 1B-adrenergic receptor that differentiates two steps in the pathway of receptor internalization. Mol. Pharmacol. 52:1997;306-313.
26. 2L dopamine receptor isoforms are differentially regulated in Chinese hamster ovary cells. Mol. Pharmacol. 45:1994;878-889.
27. 1B-adrenoceptors expressed in Chinese hamster ovary cells. Eur. J. Pharmacol. 299:1996;205-212.